US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biocryst Pharmaceuticals

6.83

-0.5000-6.82%

Post-market: 6.75-0.0760-1.11%19:18 EDT

Volume:3.51M

Turnover:24.26M

Market Cap:1.43B

PE:-15.88

High:7.18

Open:7.12

Low:6.77

Close:7.33

Loading ...

Overview Company News Filings

BioCryst Pharmaceuticals Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

BioCryst Pharmaceuticals Inc (BCRX) Q3 2024 Earnings Call Highlights: Strong ORLADEYO Growth ...

BioCryst Pharmaceuticals (BCRX) Q3 2024 Earnings Call Transcript

Motley Fool Transcribing

BioCryst Pharmaceuticals Inc reports results for the quarter ended in September 30 - Earnings Summary

Stock Track | BioCryst Shares Plunge Despite Record Q3 Revenue on Earnings Miss

BRIEF-BioCryst Reports Q3 2024 Financial Results And Provides Business Update

BioCryst Pharmaceuticals (BCRX) Reports Q3 Loss, Tops Revenue Estimates

BioCryst Pharmaceuticals Q3 Loss Narrows, Revenue Rises; 2024 Sales Guidance Issued

MT Newswires Live

Stock Track | BioCryst Shares Plunge on Q3 Earnings Miss Despite Strong Revenue Growth

BioCryst: Q3 Earnings Snapshot

Associated Press Finance

BioCryst Pharma Q3 2024 GAAP EPS $(0.07) Misses $(0.06) Estimate, Sales $117.085M Beat $112.503M Estimate

BioCryst Pharmaceuticals: Co Is Confident It Will Achieve a Full-Year Operating Profit in 2024, Not Including Non-Cash Stock Compensation

THOMSON REUTERS

BioCryst Pharmaceuticals Q3 Operating Income USD 7.692 Million VS. Ibes Estimate USD 8.18 Million

THOMSON REUTERS

BioCryst Pharmaceuticals Q3 Pretax Profit USD -13.447 Million VS. Ibes Estimate USD -13 Million

THOMSON REUTERS

BioCryst Reports Third Quarter 2024 Financial Results and Provides Business Update

BUZZ-Intellia falls as mid-stage data from gene therapy study fails to impress

How Much Upside is Left in BioCryst (BCRX)? Wall Street Analysts Think 79.5%

High Growth Tech Stocks To Watch In October 2024

Simply Wall St.

BioCryst to Report Third Quarter 2024 Financial Results on November 4

BioCryst Pharmaceuticals' Study of Orladeyo Finds Hospitalization Reduction for Hereditary Angioedema Patients

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BCRX/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BCRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCRX\",,,,,undefined,":{"symbol":"BCRX","market":"US","secType":"STK","nameCN":"Biocryst Pharmaceuticals","latestPrice":6.83,"timestamp":1743796800000,"preClose":7.33,"halted":0,"volume":3508239,"hourTrading":{"tag":"盘后","latestPrice":6.754,"preClose":6.83,"latestTime":"19:18 EDT","volume":74771,"amount":510606.27,"timestamp":1743808721095},"delay":0,"floatShares":195089922,"shares":208960020,"eps":-0.430008,"marketStatus":"Market Closed","change":-0.5,"latestTime":"04-04 16:00:00 EDT","open":7.12,"high":7.18,"low":6.77,"amount":24258721.921854,"amplitude":0.055935,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.430008,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1744012800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":762670800000,"exchange":"NASDAQ","adjPreClose":7.33,"preHourTrading":{"tag":"盘前","latestPrice":6.95,"preClose":7.33,"latestTime":"09:17 EDT","volume":163,"amount":1154.7364989999999,"timestamp":1743772670666},"postHourTrading":{"tag":"盘后","latestPrice":6.754,"preClose":6.83,"latestTime":"19:18 EDT","volume":74771,"amount":510606.27,"timestamp":1743808721095},"volumeRatio":1.5178235201605372,"impliedVol":0.5457,"impliedVolPercentile":0.5538},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCRX\",,,,,undefined,":{"symbol":"BCRX","floatShares":195089922,"roa":"-0.16%","roe":"587.33%","lyrEps":-0.430008,"volumeRatio":1.5178235201605372,"shares":208960020,"dividePrice":0,"high":7.18,"amplitude":0.055935,"preClose":7.33,"low":6.77,"week52Low":4.03,"pbRate":"-3.00","psRate":"3.17","week52High":9.5,"institutionHeld":0.9196,"latestPrice":6.83,"eps":-0.430008,"divideRate":0,"volume":3508239,"delay":0,"ttmEps":-0.430008,"open":7.12,"prevYearClose":7.52,"prevWeekClose":7.86,"prevMonthClose":7.5,"prevQuarterClose":7.5,"fiveDayClose":7.86,"twentyDayClose":7.69,"sixtyDayClose":8.14},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BCRX\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2481755865","title":"BioCryst Pharmaceuticals Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2481755865","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481755865?lang=en_us&edition=fundamental","pubTime":"2024-11-05 18:13","pubTimestamp":1730801622,"startTime":"0","endTime":"0","summary":"NasdaqGS:BCRX Earnings and Revenue Growth November 5th 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 2.7%. Earnings per share  missed analyst estimates by 12%.Looking ahead, revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 21% growth forecast for the Biotechs industry in the US.The company's shares are down 9.8% from a week ago.Before you take the next step you should know about the 2 warning signs for BioCryst Pharmaceuticals (1 is potentially serious!","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biocryst-pharmaceuticals-third-quarter-2024-101342477.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BCRX"],"gpt_icon":0},{"id":"2481542589","title":"BioCryst Pharmaceuticals Inc (BCRX) Q3 2024 Earnings Call Highlights: Strong ORLADEYO Growth ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2481542589","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481542589?lang=en_us&edition=fundamental","pubTime":"2024-11-05 15:03","pubTimestamp":1730790180,"startTime":"0","endTime":"0","summary":"ORLADEYO Revenue: $116.3 million, nearly 36% year-over-year growth.Cash Position: $351.7 million at the end of the quarter.Net Cash Flow: Positive over $13 million for the quarter.2024 Revenue Guidance for ORLADEYO: $430 million to $435 million.Total Company Revenue Guidance: $443 million to $448 million.Operating Expenses Guidance: $380 million to $390 million.GuruFocus has detected 6 Warning Signs with BCRX.For the complete transcript of the earnings call, please refer to the full earnings call transcript.BioCryst Pharmaceuticals Inc  achieved an operating profit for the quarter, excluding non-cash stock compensation.Operating expenses are expected to increase due to costs associated with advancing clinical trials and supporting the HAE community.Which group will drive more growth in the near term and long term?","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/TcY0iaqax4BzkZtEm00vmg--~B/aD0yMDA7dz0yMDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/ab32a5295b91e71f0a845370bd2aa8e9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/TcY0iaqax4BzkZtEm00vmg--~B/aD0yMDA7dz0yMDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/ab32a5295b91e71f0a845370bd2aa8e9"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biocryst-pharmaceuticals-inc-bcrx-q3-070300012.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BCRX"],"gpt_icon":0},{"id":"2481555846","title":"BioCryst Pharmaceuticals (BCRX) Q3 2024 Earnings Call Transcript","url":"https://stock-news.laohu8.com/highlight/detail?id=2481555846","media":"Motley Fool Transcribing","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481555846?lang=en_us&edition=fundamental","pubTime":"2024-11-05 03:30","pubTimestamp":1730748622,"startTime":"0","endTime":"0","summary":"BCRX earnings call for the period ending September 30, 2024.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/earnings/call-transcripts/2024/11/04/biocryst-pharmaceuticals-bcrx-q3-2024-earnings-cal/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_motley_transcript","symbols":["BCRX"],"gpt_icon":0},{"id":"2480587951","title":"BioCryst Pharmaceuticals Inc reports results for the quarter ended in September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2480587951","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480587951?lang=en_us&edition=fundamental","pubTime":"2024-11-04 23:26","pubTimestamp":1730734009,"startTime":"0","endTime":"0","summary":"* BioCryst Pharmaceuticals Inc    reported a quarterly adjusted loss of 7 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCRX"],"gpt_icon":0},{"id":"1154571416","title":"Stock Track | BioCryst Shares Plunge Despite Record Q3 Revenue on Earnings Miss","url":"https://stock-news.laohu8.com/highlight/detail?id=1154571416","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154571416?lang=en_us&edition=fundamental","pubTime":"2024-11-04 22:33","pubTimestamp":1730730828,"startTime":"0","endTime":"0","summary":"BioCryst Pharmaceuticals Inc.  saw its shares plummet over 6% in pre-market trading on November 4, 2024, after the company reported mixed third-quarter financial results. While BioCryst achieved record revenue, driven by strong sales of its flagship product ORLADEYO, the company's earnings missed analysts' expectations, prompting the sell-off.For the third quarter ended September 30, 2024, BioCryst reported a GAAP net loss of $14.0 million, or $0.07 per share, falling short of analysts' consensu","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["BCRX"],"gpt_icon":0},{"id":"2480891885","title":"BRIEF-BioCryst Reports Q3 2024 Financial Results And Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2480891885","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480891885?lang=en_us&edition=fundamental","pubTime":"2024-11-04 22:31","pubTimestamp":1730730669,"startTime":"0","endTime":"0","summary":"Nov 4  - BioCryst Pharmaceuticals Inc   :   * BIOCRYST REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE   * BIOCRYST PHARMACEUTICALS OUTLOOK 2024 TOTAL PRODUCT REVENUE GUIDANCE OF $443-$448 MILLION   * BIOCRYST PHARMACEUTICALS: CO IS CONFIDENT IT WILL ACHIEVE A FULL-YEAR OPERATING PROFIT IN 2024, NOT INCLUDING NON-CASH STOCK COMPENSATIONSource text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCRX","BK4139","BK4547"],"gpt_icon":0},{"id":"2480934584","title":"BioCryst Pharmaceuticals (BCRX) Reports Q3 Loss, Tops Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2480934584","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480934584?lang=en_us&edition=fundamental","pubTime":"2024-11-04 21:10","pubTimestamp":1730725806,"startTime":"0","endTime":"0","summary":"BioCryst Pharmaceuticals  came out with a quarterly loss of $0.07 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.19 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this drugmaker would post a loss of $0.19 per share when it actually produced a loss of $0.06, delivering a surprise of 68.42%.Over the last four quarters, the company has surpassed consensus EPS estimates two times.BioCryst , which belongs to the Zacks Medical - Drugs industry, posted revenues of $117.09 million for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 2.01%. This compares to year-ago revenues of $86.74 million. The company has topped consensus revenue estimates four times over the last four quarters.Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Drugs","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/I67vygGrP1BjgOjVx.apeA--~B/aD03Mjg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/I67vygGrP1BjgOjVx.apeA--~B/aD03Mjg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biocryst-pharmaceuticals-bcrx-reports-q3-131006068.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BCRX"],"gpt_icon":0},{"id":"2480300666","title":"BioCryst Pharmaceuticals Q3 Loss Narrows, Revenue Rises; 2024 Sales Guidance Issued","url":"https://stock-news.laohu8.com/highlight/detail?id=2480300666","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480300666?lang=en_us&edition=fundamental","pubTime":"2024-11-04 21:01","pubTimestamp":1730725319,"startTime":"0","endTime":"0","summary":"BioCryst Pharmaceuticals  reported a Q3 loss Monday of $0.07 per diluted share, narrowing from a loss of $0.19 a year earlier.Analysts polled by Capital IQ expected a loss of $0.06.Revenue for the quarter ended Sept. 30 was $117.1 million, up from $86.7 million a year earlier.Analysts surveyed by Capital IQ expected $114 million.Cash, cash equivalents, restricted cash and investments as of Sept. 30 came in at $351.7 million, compared with $399.2 million a year earlier.For 2024, the company said it expects revenue of $443 million to $448 million.Analysts surveyed by Capital IQ expect $436.3 million.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BCRX"],"gpt_icon":0},{"id":"1110489740","title":"Stock Track | BioCryst Shares Plunge on Q3 Earnings Miss Despite Strong Revenue Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1110489740","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110489740?lang=en_us&edition=fundamental","pubTime":"2024-11-04 20:12","pubTimestamp":1730722352,"startTime":"0","endTime":"0","summary":"Shares of BioCryst Pharmaceuticals  plummeted over 5% in pre-market trading on Friday, November 4, 2024, after the company reported mixed third-quarter financial results.The biopharmaceutical company, which specializes in developing treatments for rare diseases, reported a GAAP net loss of $14.0 million, or $0.07 per share, for the third quarter of 2024. This missed analysts' consensus estimate of a $0.06 loss per share and contributed to the stock's pre-market decline.However, BioCryst's revenu","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["BCRX"],"gpt_icon":0},{"id":"2480715304","title":"BioCryst: Q3 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2480715304","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480715304?lang=en_us&edition=fundamental","pubTime":"2024-11-04 20:06","pubTimestamp":1730722003,"startTime":"0","endTime":"0","summary":"DURHAM, N.C.  — DURHAM, N.C.  — BioCryst Pharmaceuticals Inc.  on Monday reported a loss of $14 million in its third quarter.The Durham, North Carolina-based company said it had a loss of 7 cents per share.The results matched Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was also for a loss of 7 cents per share.The drugmaker posted revenue of $117.1 million in the period, surpassing Street forecasts. Three analysts surveyed by Zacks expected $114.8 million.BioCryst expects full-year revenue in the range of $443 million to $448 million.BioCryst shares have risen 41% since the beginning of the year. The stock has climbed 49% in the last 12 months.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biocryst-q3-earnings-snapshot-120643222.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BCRX"],"gpt_icon":0},{"id":"2480335301","title":"BioCryst Pharma Q3 2024 GAAP EPS $(0.07) Misses $(0.06) Estimate, Sales $117.085M Beat $112.503M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2480335301","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480335301?lang=en_us&edition=fundamental","pubTime":"2024-11-04 20:01","pubTimestamp":1730721694,"startTime":"0","endTime":"0","summary":"BioCryst Pharma (NASDAQ:BCRX) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.06) by 16.67 percent. This is a 63.16 percent increase over losses of $(0.19) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41709614/biocryst-pharma-q3-2024-gaap-eps-0-07-misses-0-06-estimate-sales-117-085m-beat-112-503m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"BioCryst Pharma Q3 2024 GAAP EPS $(0.07) Misses $(0.06) Estimate, Sales $117.085M Beat $112.503M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCRX"],"gpt_icon":0},{"id":"2480301285","title":"BioCryst Pharmaceuticals: Co Is Confident It Will Achieve a Full-Year Operating Profit in 2024, Not Including Non-Cash Stock Compensation","url":"https://stock-news.laohu8.com/highlight/detail?id=2480301285","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480301285?lang=en_us&edition=fundamental","pubTime":"2024-11-04 20:00","pubTimestamp":1730721600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241104:nTUA11TTYD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCRX","BK4547","BK4139"],"gpt_icon":0},{"id":"2480301813","title":"BioCryst Pharmaceuticals Q3 Operating Income USD 7.692 Million VS. Ibes Estimate USD 8.18 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2480301813","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480301813?lang=en_us&edition=fundamental","pubTime":"2024-11-04 20:00","pubTimestamp":1730721600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241104:nPLXC7B0F6:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCRX","BK4547","BK4139"],"gpt_icon":0},{"id":"2480301596","title":"BioCryst Pharmaceuticals Q3 Pretax Profit USD -13.447 Million VS. Ibes Estimate USD -13 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2480301596","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480301596?lang=en_us&edition=fundamental","pubTime":"2024-11-04 20:00","pubTimestamp":1730721600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241104:nPLXC7B0F6:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4547","BCRX","BK4139"],"gpt_icon":0},{"id":"2480630116","title":"BioCryst Reports Third Quarter 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2480630116","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480630116?lang=en_us&edition=fundamental","pubTime":"2024-11-04 20:00","pubTimestamp":1730721600,"startTime":"0","endTime":"0","summary":"— Q3 2024 ORLADEYO net revenue of $116.3 million  —。— Full-year 2024 ORLADEYO revenue guidance adjusted to $430-$435 million  —。— Company introduces full-year 2024 total product revenue guidance of $443-$448 million based on additional 2024 revenue from RAPIVAB —。— BCX17725 for Netherton syndrome advances into the clinic —。— Company generates GAAP operating profit of $7.7 million in third quarter  —。RESEARCH TRIANGLE PARK, N.C., Nov. 04, 2024  -- BioCryst Pharmaceuticals, Inc.  today reported financial results for the third quarter ended September 30, 2024, and provided a corporate update.“Our thirdquarter performance continues to build on the outstanding year we are having, with significant revenue growth, strong patient demand, pipeline advancement and operating profitability in the quarter. As we look ahead, we see robust and durable revenue growth, new opportunities for younger children to benefit from ORLADEYO, and data readouts from BCX17725 in Netherton syndrome and avoralstat i","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ukm4YNhEej_10a70HKOrLA--~B/aD05MDU7dz0yMzEyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/00281489c7a24a3d55bb9caac0266f4a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ukm4YNhEej_10a70HKOrLA--~B/aD05MDU7dz0yMzEyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/00281489c7a24a3d55bb9caac0266f4a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biocryst-reports-third-quarter-2024-120000480.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4122","IE00BLDYK493.USD","BCRX","LU1169590202.USD","LU0106261612.USD","HAE","LU0205193047.USD","LU0205194284.USD","BK4139","BK4198","IE00B64QTZ34.USD","LU0012050646.USD","BK4094","PIK","LU1169589451.USD","BK4547"],"gpt_icon":0},{"id":"2477598630","title":"BUZZ-Intellia falls as mid-stage data from gene therapy study fails to impress","url":"https://stock-news.laohu8.com/highlight/detail?id=2477598630","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477598630?lang=en_us&edition=fundamental","pubTime":"2024-10-24 22:31","pubTimestamp":1729780267,"startTime":"0","endTime":"0","summary":"** Gene editing firm Intellia Therapeutics'    shares fall 18% to $16.38   ** Company says its experimental gene therapy to treat a rare disorder called hereditary angioedema  helped reduce monthly swelling attacks by up to 81% vs placebo in a mid-stage study   ** HAE is characterized by unpredictable and frequent severe swelling of the skin, gastrointestinal tract, upper respiratory system, face and throat   ** \"We expect investors will view the ~75-80% reduction in HAE attacks as less than impressive in the context of the potential risks of in vivo gene editing and the competitive landscape in this indication\" - brokerage Baird   ** HAE treatments in the U.S. that are currently approved include drugs made by Takeda Pharmaceuticals    and BioCryst Pharmaceuticals      ** Including session moves, Intellia shares down ~46% YTD ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","LU0205193047.USD","LU0205194284.USD","LU0012050646.USD","IE00B64QTZ34.USD","BK4556","LU1169590202.USD","LU1861559042.SGD","BK4585","LU1169589451.USD","BK4588","LU0106261612.USD","LU1861558580.USD","BK4547","IE00BLDYK493.USD","BCRX","NTLA","HAE","BK4139","BK4198"],"gpt_icon":1},{"id":"2477253534","title":"How Much Upside is Left in BioCryst (BCRX)? Wall Street Analysts Think 79.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477253534","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477253534?lang=en_us&edition=fundamental","pubTime":"2024-10-23 21:55","pubTimestamp":1729691704,"startTime":"0","endTime":"0","summary":"BioCryst Pharmaceuticals  closed the last trading session at $7.95, gaining 4.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $14.27 indicates a 79.5% upside potential.The mean estimate comprises 11 short-term price targets with a standard deviation of $6.71. While the lowest estimate of $7 indicates a 12% decline from the current price level, the most optimistic analyst expects the stock to surge 277.4% to reach $30. It's very important to note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.That said, while investors should not entirely ignore price targets, making an investment decision solely based on them could lead to disappointing ROI. So, price targets should always be treated w","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/xopQugjeNyS1VO21qlHkcQ--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3cb5117fc22f5e37890d1860dcd61f9f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/xopQugjeNyS1VO21qlHkcQ--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3cb5117fc22f5e37890d1860dcd61f9f"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/much-upside-left-biocryst-bcrx-135504068.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BCRX","BK4547"],"gpt_icon":0},{"id":"2477301918","title":"High Growth Tech Stocks To Watch In October 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2477301918","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477301918?lang=en_us&edition=fundamental","pubTime":"2024-10-23 18:07","pubTimestamp":1729678061,"startTime":"0","endTime":"0","summary":"In the last week, the United States market has been flat, yet it has shown significant strength over the past year with a 37% increase and earnings forecasted to grow by 15% annually. In this context, identifying high growth tech stocks involves looking for companies that demonstrate strong potential for innovation and scalability in alignment with these robust market conditions.Top 10 High Growth Tech Companies In The United States. NasdaqGM:GDS Revenue and Expenses Breakdown as at Oct 2024. Overview: Alkami Technology, Inc. provides cloud-based digital banking solutions in the United States and has a market capitalization of approximately $3.78 billion.Alkami Technology, despite a challenging financial landscape marked by a net loss of $12.32 million in Q2 2024, is makin","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/3wFOxca.gMo3EgB9BjBM9g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/41bdd0c670f621394929d5266c5d6c72","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/3wFOxca.gMo3EgB9BjBM9g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/41bdd0c670f621394929d5266c5d6c72"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/high-growth-tech-stocks-watch-100741279.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ALKT","GDS","BK4539","BK4023","BCRX"],"gpt_icon":0},{"id":"2477170853","title":"BioCryst to Report Third Quarter 2024 Financial Results on November 4","url":"https://stock-news.laohu8.com/highlight/detail?id=2477170853","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477170853?lang=en_us&edition=fundamental","pubTime":"2024-10-21 19:00","pubTimestamp":1729508400,"startTime":"0","endTime":"0","summary":"RESEARCH TRIANGLE PARK, N.C., Oct. 21, 2024  -- BioCryst Pharmaceuticals, Inc.  today announced that the company will report its third quarter 2024 financial results on Monday, November 4, 2024.BioCryst management will host a conference call and webcast at 8:30 a.m. ET that day to discuss the financial results and provide a corporate update.The live call may be accessed by dialing 1-844-481-2942 for domestic callers and 1-412-317-1866 for international callers. A live webcast and replay of the call will be available online in the investors section of the company website at www.biocryst.com.About BioCryst Pharmaceuticals BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with complement-mediated and other rare diseases. BioCryst leverages its expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. BioCryst","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ukm4YNhEej_10a70HKOrLA--~B/aD05MDU7dz0yMzEyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/00281489c7a24a3d55bb9caac0266f4a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ukm4YNhEej_10a70HKOrLA--~B/aD05MDU7dz0yMzEyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/00281489c7a24a3d55bb9caac0266f4a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biocryst-report-third-quarter-2024-110000503.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4547","BK4139","BCRX"],"gpt_icon":0},{"id":"2475365281","title":"BioCryst Pharmaceuticals' Study of Orladeyo Finds Hospitalization Reduction for Hereditary Angioedema Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2475365281","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475365281?lang=en_us&edition=fundamental","pubTime":"2024-10-14 20:25","pubTimestamp":1728908750,"startTime":"0","endTime":"0","summary":"BioCryst Pharmaceuticals  said Monday a study of berotralstat, which it markets under the brand name of Orladeyo, showed a significant reduction in hospitalizations, emergency room visits, and use of on-demand therapies for patients with hereditary angioedema in the US.The company said that the study of berotralstat will be presented at the Academy of Managed Care Pharmacy Nexus 2024 national meeting being held in Las Vegas, Nevada, this week.Price: 7.59, Change: +0.16, Percent Change: +2.15","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4547","BK4139","BCRX"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":6,"totalSize":124}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BCRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-24","symbol":"BCRX","fiscalQuarterEnding":"2024/12","expectedEps":-0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740373200000,"reportTimeType":"pre","actualEps":-0.13},{"date":"2025-01-10","symbol":"BCRX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1736499600000,"name":null,"time":"Pre-Market","dateTimestamp":1736485200000,"actualEps":null},{"market":"US","date":"2024-11-04","symbol":"BCRX","fiscalQuarterEnding":"2024/09","expectedEps":-0.07,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730696400000,"reportTimeType":"pre","actualEps":-0.07},{"market":"US","date":"2024-08-05","symbol":"BCRX","fiscalQuarterEnding":"2024/06","expectedEps":-0.19,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722830400000,"reportTimeType":"pre","actualEps":-0.06},{"market":"US","date":"2024-05-06","symbol":"BCRX","fiscalQuarterEnding":"2024/03","expectedEps":-0.23,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1714968000000,"reportTimeType":"pre","actualEps":-0.17}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BCRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BCRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.6667,"hold":0.0833,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":12,"updateTime":1740542400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BCRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BCRX","date":"2025-04-04","current":-17.232895,"percent":0.025162,"low":-20.242186,"twenty":-12.640439,"median":-10.100661,"eighty":-5.812016,"high":-2.74693,"avg":-9.532388,"sd":3.649335,"marketCap":1531676946},"quantilePoints":[{"date":"2020-04-09","current":-2.931002,"twenty":-13.296513,"median":-8.729414,"eighty":-4.270472,"marketCap":319177338},{"date":"2020-04-17","current":-4.757569,"twenty":-13.166215,"median":-8.694722,"eighty":-4.205902,"marketCap":518084955},{"date":"2020-04-24","current":-5.042892,"twenty":-12.997188,"median":-8.596328,"eighty":-4.205902,"marketCap":549155799},{"date":"2020-05-01","current":-5.014561,"twenty":-12.787091,"median":-8.555141,"eighty":-4.205902,"marketCap":546070654},{"date":"2020-05-08","current":-6.280288,"twenty":-12.613187,"median":-8.517123,"eighty":-4.205902,"marketCap":725009060},{"date":"2020-05-15","current":-7.068481,"twenty":-12.467817,"median":-8.441211,"eighty":-4.205902,"marketCap":815999560},{"date":"2020-05-22","current":-7.282272,"twenty":-12.266122,"median":-8.389594,"eighty":-4.205902,"marketCap":840680076},{"date":"2020-05-29","current":-6.738791,"twenty":-12.190824,"median":-8.369631,"eighty":-4.205902,"marketCap":777939567},{"date":"2020-06-05","current":-6.371966,"twenty":-12.070333,"median":-8.328245,"eighty":-4.205902,"marketCap":735592549},{"date":"2020-06-12","current":-6.555332,"twenty":-12.005198,"median":-8.262066,"eighty":-4.205902,"marketCap":756760680},{"date":"2020-06-19","current":-5.944113,"twenty":-11.838182,"median":-8.190107,"eighty":-4.205902,"marketCap":686200243},{"date":"2020-06-26","current":-7.380479,"twenty":-11.682369,"median":-8.144796,"eighty":-4.205902,"marketCap":852017269},{"date":"2020-07-02","current":-7.670809,"twenty":-11.496854,"median":-8.11279,"eighty":-4.205902,"marketCap":885533476},{"date":"2020-07-10","current":-8.304949,"twenty":-11.424027,"median":-8.104178,"eighty":-4.205902,"marketCap":958739929},{"date":"2020-07-17","current":-7.693729,"twenty":-11.363575,"median":-8.091787,"eighty":-4.205902,"marketCap":888179493},{"date":"2020-07-24","current":-6.79982,"twenty":-11.319688,"median":-8.057043,"eighty":-4.205902,"marketCap":784984854},{"date":"2020-07-31","current":-6.219161,"twenty":-11.274791,"median":-7.994153,"eighty":-4.205902,"marketCap":717952440},{"date":"2020-08-07","current":-6.016347,"twenty":-11.160309,"median":-7.96967,"eighty":-4.205902,"marketCap":700423130},{"date":"2020-08-14","current":-6.529076,"twenty":-11.106194,"median":-7.900285,"eighty":-4.205902,"marketCap":760115002},{"date":"2020-08-21","current":-6.316748,"twenty":-11.077065,"median":-7.856248,"eighty":-4.205902,"marketCap":735395815},{"date":"2020-08-28","current":-6.021006,"twenty":-11.015049,"median":-7.837103,"eighty":-4.205902,"marketCap":700965519},{"date":"2020-09-04","current":-5.543269,"twenty":-10.97726,"median":-7.769011,"eighty":-4.205902,"marketCap":645347348},{"date":"2020-09-11","current":-5.717681,"twenty":-10.911122,"median":-7.755135,"eighty":-4.205902,"marketCap":665652394},{"date":"2020-09-18","current":-6.081671,"twenty":-10.880898,"median":-7.699255,"eighty":-4.205902,"marketCap":708028144},{"date":"2020-09-25","current":-5.520519,"twenty":-10.839022,"median":-7.665311,"eighty":-4.205902,"marketCap":642698864},{"date":"2020-10-02","current":-5.11103,"twenty":-10.793572,"median":-7.626496,"eighty":-4.205902,"marketCap":595026146},{"date":"2020-10-09","current":-5.930008,"twenty":-10.707271,"median":-7.592474,"eighty":-4.205902,"marketCap":690371582},{"date":"2020-10-16","current":-5.831428,"twenty":-10.67549,"median":-7.566451,"eighty":-4.205902,"marketCap":678894816},{"date":"2020-10-23","current":-5.626683,"twenty":-10.628603,"median":-7.541711,"eighty":-4.205902,"marketCap":655058457},{"date":"2020-10-30","current":-5.793512,"twenty":-10.593781,"median":-7.507575,"eighty":-4.205902,"marketCap":674480676},{"date":"2020-11-06","current":-5.765731,"twenty":-10.551983,"median":-7.486092,"eighty":-4.205902,"marketCap":720387737},{"date":"2020-11-13","current":-6.232077,"twenty":-10.538074,"median":-7.452068,"eighty":-4.205902,"marketCap":778654393},{"date":"2020-11-20","current":-6.119023,"twenty":-10.502556,"median":-7.415752,"eighty":-4.205902,"marketCap":764529143},{"date":"2020-11-27","current":-7.249559,"twenty":-10.486965,"median":-7.377742,"eighty":-4.205902,"marketCap":905781640},{"date":"2020-12-04","current":-8.620333,"twenty":-10.443543,"median":-7.364834,"eighty":-4.205902,"marketCap":1077050294},{"date":"2020-12-11","current":-11.474935,"twenty":-10.439991,"median":-7.364834,"eighty":-4.205902,"marketCap":1433712850},{"date":"2020-12-18","current":-12.167388,"twenty":-10.439991,"median":-7.364834,"eighty":-4.205902,"marketCap":1520230005},{"date":"2020-12-24","current":-10.287873,"twenty":-10.42216,"median":-7.364834,"eighty":-4.205902,"marketCap":1285397728},{"date":"2020-12-31","current":-10.528112,"twenty":-10.406422,"median":-7.364834,"eighty":-4.205902,"marketCap":1315413883},{"date":"2021-01-08","current":-10.937931,"twenty":-10.406422,"median":-7.364834,"eighty":-4.205902,"marketCap":1366617914},{"date":"2021-01-15","current":-12.435891,"twenty":-10.406422,"median":-7.364834,"eighty":-4.205902,"marketCap":1553777473},{"date":"2021-01-22","current":-13.01529,"twenty":-10.406422,"median":-7.364834,"eighty":-4.205902,"marketCap":1626169378},{"date":"2021-01-29","current":-12.040203,"twenty":-10.406422,"median":-7.364834,"eighty":-4.205902,"marketCap":1504339099},{"date":"2021-02-05","current":-13.834928,"twenty":-10.406422,"median":-7.364834,"eighty":-4.205902,"marketCap":1728577439},{"date":"2021-02-12","current":-13.524031,"twenty":-10.425697,"median":-7.377742,"eighty":-4.270472,"marketCap":1689733002},{"date":"2021-02-19","current":-16.293843,"twenty":-10.451735,"median":-7.415752,"eighty":-4.311563,"marketCap":2035801621},{"date":"2021-02-26","current":-10.430267,"twenty":-10.486965,"median":-7.452068,"eighty":-4.370264,"marketCap":1906798740},{"date":"2021-03-05","current":-10.827217,"twenty":-10.502556,"median":-7.492474,"eighty":-4.387874,"marketCap":1979366876},{"date":"2021-03-12","current":-12.274083,"twenty":-10.531336,"median":-7.509913,"eighty":-4.387874,"marketCap":2243874199},{"date":"2021-03-19","current":-12.856713,"twenty":-10.550622,"median":-7.54353,"eighty":-4.387874,"marketCap":2350387215},{"date":"2021-03-26","current":-10.050376,"twenty":-10.551983,"median":-7.566451,"eighty":-4.387874,"marketCap":1837349522},{"date":"2021-04-01","current":-9.661956,"twenty":-10.551983,"median":-7.586092,"eighty":-4.387874,"marketCap":1766340845},{"date":"2021-04-09","current":-9.914429,"twenty":-10.553344,"median":-7.620114,"eighty":-4.387874,"marketCap":1812496485},{"date":"2021-04-16","current":-10.922381,"twenty":-10.566007,"median":-7.659812,"eighty":-4.387874,"marketCap":1996764194},{"date":"2021-04-23","current":-11.787232,"twenty":-10.598721,"median":-7.693729,"eighty":-4.387874,"marketCap":2154870967},{"date":"2021-04-30","current":-11.306219,"twenty":-10.62745,"median":-7.749751,"eighty":-4.387874,"marketCap":2066935178},{"date":"2021-05-07","current":-11.128348,"twenty":-10.658596,"median":-7.773282,"eighty":-4.387874,"marketCap":2331377738},{"date":"2021-05-14","current":-10.890853,"twenty":-10.671602,"median":-7.837103,"eighty":-4.459566,"marketCap":2281622726},{"date":"2021-05-21","current":-11.756014,"twenty":-10.694822,"median":-7.86263,"eighty":-4.459566,"marketCap":2462873129},{"date":"2021-05-28","current":-13.376071,"twenty":-10.7384,"median":-7.900922,"eighty":-4.459566,"marketCap":2802273394},{"date":"2021-06-04","current":-13.817133,"twenty":-10.776869,"median":-7.964742,"eighty":-4.459566,"marketCap":2894675561},{"date":"2021-06-11","current":-14.173376,"twenty":-10.812443,"median":-7.991699,"eighty":-4.459566,"marketCap":2969308080},{"date":"2021-06-18","current":-13.477854,"twenty":-10.832125,"median":-8.049548,"eighty":-4.528755,"marketCap":2823596971},{"date":"2021-06-25","current":-14.529619,"twenty":-10.856239,"median":-8.091771,"eighty":-4.673219,"marketCap":3043940599},{"date":"2021-07-02","current":-13.978291,"twenty":-10.888594,"median":-8.100687,"eighty":-4.860319,"marketCap":2928437891},{"date":"2021-07-09","current":-13.876507,"twenty":-10.915626,"median":-8.124497,"eighty":-4.933165,"marketCap":2907114314},{"date":"2021-07-16","current":-13.240359,"twenty":-10.957099,"median":-8.171135,"eighty":-5.037226,"marketCap":2773841959},{"date":"2021-07-23","current":-14.639884,"twenty":-11.007255,"median":-8.244416,"eighty":-5.112966,"marketCap":3067041141},{"date":"2021-07-30","current":-13.67294,"twenty":-11.038429,"median":-8.297309,"eighty":-5.206578,"marketCap":2864467160},{"date":"2021-08-06","current":-14.701047,"twenty":-11.097241,"median":-8.334355,"eighty":-5.206578,"marketCap":3147347250},{"date":"2021-08-13","current":-13.493154,"twenty":-11.097675,"median":-8.334355,"eighty":-5.206578,"marketCap":2888749337},{"date":"2021-08-20","current":-11.872305,"twenty":-11.12179,"median":-8.334355,"eighty":-5.206578,"marketCap":2541741676},{"date":"2021-08-27","current":-13.083764,"twenty":-11.176176,"median":-8.334355,"eighty":-5.206578,"marketCap":2801103072},{"date":"2021-09-03","current":-13.083764,"twenty":-11.272485,"median":-8.334355,"eighty":-5.206578,"marketCap":2801103072},{"date":"2021-09-10","current":-12.699439,"twenty":-11.290353,"median":-8.334355,"eighty":-5.206578,"marketCap":2718822905},{"date":"2021-09-17","current":-13.117184,"twenty":-11.324018,"median":-8.334355,"eighty":-5.206578,"marketCap":2808257869},{"date":"2021-09-24","current":-12.465502,"twenty":-11.369016,"median":-8.334355,"eighty":-5.206578,"marketCap":2668739325},{"date":"2021-10-01","current":-11.47127,"twenty":-11.405963,"median":-8.334355,"eighty":-5.206578,"marketCap":2455884111},{"date":"2021-10-08","current":-12.081177,"twenty":-11.447508,"median":-8.334355,"eighty":-5.206578,"marketCap":2586459158},{"date":"2021-10-15","current":-12.640955,"twenty":-11.477201,"median":-8.334355,"eighty":-5.206578,"marketCap":2706302010},{"date":"2021-10-22","current":-12.281694,"twenty":-11.564062,"median":-8.334355,"eighty":-5.206578,"marketCap":2629387941},{"date":"2021-10-29","current":-12.473857,"twenty":-11.671007,"median":-8.334355,"eighty":-5.206578,"marketCap":2670528025},{"date":"2021-11-05","current":-9.846756,"twenty":-11.693218,"median":-8.334355,"eighty":-5.206578,"marketCap":2233007882},{"date":"2021-11-12","current":-9.719803,"twenty":-11.693218,"median":-8.334355,"eighty":-5.206578,"marketCap":2204218094},{"date":"2021-11-19","current":-9.43416,"twenty":-11.671007,"median":-8.334355,"eighty":-5.206578,"marketCap":2139441073},{"date":"2021-11-26","current":-9.902297,"twenty":-11.566663,"median":-8.334355,"eighty":-5.206578,"marketCap":2245603414},{"date":"2021-12-03","current":-9.077106,"twenty":-11.566663,"median":-8.334355,"eighty":-5.206578,"marketCap":2058469796},{"date":"2021-12-10","current":-9.243731,"twenty":-11.566663,"median":-8.334355,"eighty":-5.206578,"marketCap":2096256392},{"date":"2021-12-17","current":-10.338697,"twenty":-11.547357,"median":-8.334355,"eighty":-5.206578,"marketCap":2344568308},{"date":"2021-12-23","current":-11.04487,"twenty":-11.472736,"median":-8.334355,"eighty":-5.206578,"marketCap":2504711500},{"date":"2021-12-31","current":-10.989329,"twenty":-11.41685,"median":-8.334355,"eighty":-5.206578,"marketCap":2492115968},{"date":"2022-01-07","current":-9.17232,"twenty":-11.336787,"median":-8.340324,"eighty":-5.208094,"marketCap":2080062136},{"date":"2022-01-14","current":-12.282657,"twenty":-11.336787,"median":-8.340324,"eighty":-5.208094,"marketCap":2785411927},{"date":"2022-01-21","current":-10.933787,"twenty":-11.304581,"median":-8.340324,"eighty":-5.208094,"marketCap":2479520436},{"date":"2022-01-28","current":-11.798651,"twenty":-11.300042,"median":-8.340324,"eighty":-5.208094,"marketCap":2675650862},{"date":"2022-02-04","current":-12.068425,"twenty":-11.300042,"median":-8.340324,"eighty":-5.208094,"marketCap":2736829160},{"date":"2022-02-11","current":-14.115535,"twenty":-11.300042,"median":-8.340324,"eighty":-5.208094,"marketCap":3201064482},{"date":"2022-02-18","current":-14.869315,"twenty":-11.300042,"median":-8.340324,"eighty":-5.208094,"marketCap":3372003844},{"date":"2022-02-25","current":-17.086694,"twenty":-11.307904,"median":-8.340324,"eighty":-5.208094,"marketCap":3145011000},{"date":"2022-03-04","current":-16.152465,"twenty":-11.317818,"median":-8.340324,"eighty":-5.208094,"marketCap":2973054963},{"date":"2022-03-11","current":-16.17253,"twenty":-11.317818,"median":-8.340324,"eighty":-5.208094,"marketCap":2976748199},{"date":"2022-03-18","current":-16.272856,"twenty":-11.317818,"median":-8.340324,"eighty":-5.208094,"marketCap":2995214379},{"date":"2022-03-25","current":-16.042106,"twenty":-11.317818,"median":-8.340324,"eighty":-5.208094,"marketCap":2952742166},{"date":"2022-04-01","current":-16.644061,"twenty":-11.317818,"median":-8.340324,"eighty":-5.208094,"marketCap":3063539245},{"date":"2022-04-08","current":-11.156237,"twenty":-11.307904,"median":-8.340324,"eighty":-5.208094,"marketCap":2053439204},{"date":"2022-04-14","current":-11.4221,"twenty":-11.290289,"median":-8.340324,"eighty":-5.208094,"marketCap":2102374581},{"date":"2022-04-22","current":-9.701511,"twenty":-11.173318,"median":-8.340324,"eighty":-5.208094,"marketCap":1785679596},{"date":"2022-04-29","current":-9.366496,"twenty":-11.102733,"median":-8.340324,"eighty":-5.208094,"marketCap":1724015904},{"date":"2022-05-06","current":-8.696528,"twenty":-11.021077,"median":-8.340324,"eighty":-5.208094,"marketCap":1686900384},{"date":"2022-05-13","current":-8.027101,"twenty":-11.021077,"median":-8.301129,"eighty":-5.208094,"marketCap":1557048887},{"date":"2022-05-20","current":-8.706391,"twenty":-11.021077,"median":-8.282296,"eighty":-5.208094,"marketCap":1688813453},{"date":"2022-05-27","current":-9.337843,"twenty":-11.021077,"median":-8.294118,"eighty":-5.208094,"marketCap":1811298824},{"date":"2022-06-03","current":-9.997998,"twenty":-11.021077,"median":-8.301129,"eighty":-5.208094,"marketCap":1939351713},{"date":"2022-06-10","current":-9.433518,"twenty":-11.021077,"median":-8.301129,"eighty":-5.208094,"marketCap":1829857214},{"date":"2022-06-17","current":-9.203899,"twenty":-11.021077,"median":-8.301129,"eighty":-5.208094,"marketCap":1785317079},{"date":"2022-06-24","current":-10.29459,"twenty":-11.0226,"median":-8.297309,"eighty":-5.206578,"marketCap":1996882720},{"date":"2022-07-01","current":-10.371129,"twenty":-11.0226,"median":-8.297309,"eighty":-5.206578,"marketCap":2011729432},{"date":"2022-07-08","current":-11.557495,"twenty":-11.05766,"median":-8.297309,"eighty":-5.206578,"marketCap":2241853463},{"date":"2022-07-15","current":-11.146094,"twenty":-11.094816,"median":-8.297309,"eighty":-5.206578,"marketCap":2162052388},{"date":"2022-07-22","current":-10.629451,"twenty":-11.135446,"median":-8.297309,"eighty":-5.206578,"marketCap":2061837084},{"date":"2022-07-29","current":-10.543344,"twenty":-11.135446,"median":-8.334355,"eighty":-5.206578,"marketCap":2045134533},{"date":"2022-08-05","current":-12.462268,"twenty":-11.150151,"median":-8.374928,"eighty":-5.206578,"marketCap":2612527474},{"date":"2022-08-12","current":-12.985594,"twenty":-11.22776,"median":-8.407601,"eighty":-5.296059,"marketCap":2722235034},{"date":"2022-08-19","current":-12.533227,"twenty":-11.309589,"median":-8.455336,"eighty":-5.414226,"marketCap":2627403076},{"date":"2022-08-26","current":-12.648536,"twenty":-11.405675,"median":-8.531039,"eighty":-5.512419,"marketCap":2651575928},{"date":"2022-09-02","current":-12.480008,"twenty":-11.459768,"median":-8.596328,"eighty":-5.512419,"marketCap":2616246375},{"date":"2022-09-09","current":-11.930071,"twenty":-11.491893,"median":-8.652683,"eighty":-5.514453,"marketCap":2500960465},{"date":"2022-09-16","current":-11.663973,"twenty":-11.547357,"median":-8.701649,"eighty":-5.514453,"marketCap":2445176960},{"date":"2022-09-23","current":-10.963248,"twenty":-11.566478,"median":-8.729414,"eighty":-5.514453,"marketCap":2298280397},{"date":"2022-09-30","current":-11.176126,"twenty":-11.566478,"median":-8.857482,"eighty":-5.514453,"marketCap":2342907201},{"date":"2022-10-07","current":-12.11634,"twenty":-11.645286,"median":-8.89774,"eighty":-5.514453,"marketCap":2540008918},{"date":"2022-10-14","current":-12.001031,"twenty":-11.717338,"median":-8.933652,"eighty":-5.514453,"marketCap":2515836066},{"date":"2022-10-21","current":-12.542097,"twenty":-11.764614,"median":-9.020394,"eighty":-5.514453,"marketCap":2629262526},{"date":"2022-10-28","current":-12.453398,"twenty":-11.858323,"median":-9.042565,"eighty":-5.514453,"marketCap":2610668024},{"date":"2022-11-04","current":-11.994127,"twenty":-11.860318,"median":-9.07511,"eighty":-5.514453,"marketCap":2319112507},{"date":"2022-11-11","current":-12.697963,"twenty":-11.880929,"median":-9.17232,"eighty":-5.514453,"marketCap":2455201906},{"date":"2022-11-18","current":-11.984486,"twenty":-11.950615,"median":-9.209248,"eighty":-5.514453,"marketCap":2317248269},{"date":"2022-11-25","current":-11.839862,"twenty":-11.968356,"median":-9.243731,"eighty":-5.514453,"marketCap":2289284693},{"date":"2022-12-02","current":-12.331583,"twenty":-11.996889,"median":-9.311375,"eighty":-5.514453,"marketCap":2384360849},{"date":"2022-12-09","current":-10.123661,"twenty":-11.996889,"median":-9.356661,"eighty":-5.514453,"marketCap":1957450267},{"date":"2022-12-16","current":-10.54789,"twenty":-11.996889,"median":-9.390672,"eighty":-5.514453,"marketCap":2039476754},{"date":"2022-12-23","current":-11.039611,"twenty":-11.996889,"median":-9.418291,"eighty":-5.514453,"marketCap":2134552910},{"date":"2022-12-30","current":-11.068536,"twenty":-11.996889,"median":-9.433518,"eighty":-5.514453,"marketCap":2140145625},{"date":"2023-01-06","current":-11.396349,"twenty":-11.996889,"median":-9.433518,"eighty":-5.514453,"marketCap":2203529729},{"date":"2023-01-13","current":-9.795847,"twenty":-11.996889,"median":-9.433518,"eighty":-5.514453,"marketCap":1894066163},{"date":"2023-01-20","current":-10.027245,"twenty":-11.996889,"median":-9.433518,"eighty":-5.514453,"marketCap":1938807884},{"date":"2023-01-27","current":-10.200793,"twenty":-11.996889,"median":-9.44347,"eighty":-5.514453,"marketCap":1972364174},{"date":"2023-02-03","current":-10.171868,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1966771459},{"date":"2023-02-10","current":-9.940471,"twenty":-11.996889,"median":-9.477022,"eighty":-5.514453,"marketCap":1922029738},{"date":"2023-02-17","current":-9.834413,"twenty":-11.996889,"median":-9.500944,"eighty":-5.514453,"marketCap":1901523117},{"date":"2023-02-24","current":-6.919603,"twenty":-11.996889,"median":-9.471788,"eighty":-5.514453,"marketCap":1709944600},{"date":"2023-03-03","current":-6.703271,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1656485494},{"date":"2023-03-10","current":-6.32197,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1562259925},{"date":"2023-03-17","current":-6.177076,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1526454209},{"date":"2023-03-24","current":-6.482116,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1601834664},{"date":"2023-03-31","current":-6.3601,"twenty":-11.995508,"median":-9.460929,"eighty":-5.517486,"marketCap":1571682482},{"date":"2023-04-06","current":-6.504994,"twenty":-11.995508,"median":-9.460929,"eighty":-5.517486,"marketCap":1607488198},{"date":"2023-04-14","current":-6.413482,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1584874062},{"date":"2023-04-21","current":-5.628002,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1390769391},{"date":"2023-04-28","current":-5.756703,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1422573360},{"date":"2023-05-05","current":-7.072432,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1600158879},{"date":"2023-05-12","current":-6.980582,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1579377595},{"date":"2023-05-19","current":-6.989451,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1581384167},{"date":"2023-05-26","current":-6.672128,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1509588948},{"date":"2023-06-02","current":-7.006152,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1585162862},{"date":"2023-06-09","current":-7.356877,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1664515473},{"date":"2023-06-16","current":-6.663777,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1507699600},{"date":"2023-06-23","current":-5.845419,"twenty":-11.998269,"median":-9.468843,"eighty":-5.511419,"marketCap":1322543509},{"date":"2023-06-30","current":-5.812016,"twenty":-11.99965,"median":-9.471788,"eighty":-5.508386,"marketCap":1314986117},{"date":"2023-07-07","current":-5.812016,"twenty":-11.99965,"median":-9.471788,"eighty":-5.508386,"marketCap":1314986117},{"date":"2023-07-14","current":-6.13769,"twenty":-11.99965,"median":-9.471788,"eighty":-5.508386,"marketCap":1388670684},{"date":"2023-07-21","current":-5.987379,"twenty":-11.99965,"median":-9.471788,"eighty":-5.508386,"marketCap":1354662422},{"date":"2023-07-28","current":-6.471714,"twenty":-11.99965,"median":-9.471788,"eighty":-5.508386,"marketCap":1464244599},{"date":"2023-08-04","current":-5.527341,"twenty":-11.99965,"median":-9.471788,"eighty":-5.487548,"marketCap":1341596280},{"date":"2023-08-11","current":-5.519614,"twenty":-11.99965,"median":-9.45596,"eighty":-5.447182,"marketCap":1339720706},{"date":"2023-08-18","current":-5.464964,"twenty":-11.99965,"median":-9.433518,"eighty":-5.42126,"marketCap":1326456145},{"date":"2023-08-25","current":-5.652335,"twenty":-11.99965,"median":-9.412435,"eighty":-5.42126,"marketCap":1371934641},{"date":"2023-09-01","current":-5.550842,"twenty":-11.99965,"median":-9.381701,"eighty":-5.418337,"marketCap":1347300455},{"date":"2023-09-08","current":-5.347858,"twenty":-11.99965,"median":-9.34688,"eighty":-5.418122,"marketCap":1298032084},{"date":"2023-09-15","current":-5.402508,"twenty":-11.99965,"median":-9.253895,"eighty":-5.403361,"marketCap":1311296646},{"date":"2023-09-22","current":-5.589878,"twenty":-11.99965,"median":-9.209248,"eighty":-5.402508,"marketCap":1356775142},{"date":"2023-09-29","current":-5.652335,"twenty":-11.99965,"median":-9.17232,"eighty":-5.402508,"marketCap":1371934641},{"date":"2023-10-06","current":-5.176102,"twenty":-11.99965,"median":-9.07511,"eighty":-5.347858,"marketCap":1256343463},{"date":"2023-10-13","current":-4.668641,"twenty":-11.99965,"median":-9.042565,"eighty":-5.279367,"marketCap":1133172535},{"date":"2023-10-20","current":-4.465657,"twenty":-11.99965,"median":-8.948564,"eighty":-5.203545,"marketCap":1083904164},{"date":"2023-10-27","current":-4.262672,"twenty":-12.001031,"median":-8.93448,"eighty":-5.139124,"marketCap":1034635793},{"date":"2023-11-03","current":-4.529272,"twenty":-12.001031,"median":-8.88682,"eighty":-5.005907,"marketCap":1070488920},{"date":"2023-11-10","current":-4.34144,"twenty":-12.001031,"median":-8.834028,"eighty":-4.882775,"marketCap":1026094993},{"date":"2023-11-17","current":-4.454092,"twenty":-12.001031,"median":-8.801384,"eighty":-4.760324,"marketCap":1052720213},{"date":"2023-11-24","current":-4.783383,"twenty":-12.001031,"median":-8.70402,"eighty":-4.675094,"marketCap":1130547777},{"date":"2023-12-01","current":-5.095343,"twenty":-12.001031,"median":-8.655618,"eighty":-4.65615,"marketCap":1204279154},{"date":"2023-12-08","current":-4.913366,"twenty":-12.001031,"median":-8.596328,"eighty":-4.662395,"marketCap":1161269184},{"date":"2023-12-15","current":-5.571948,"twenty":-12.001031,"median":-8.515042,"eighty":-4.662395,"marketCap":1316924313},{"date":"2023-12-22","current":-4.991356,"twenty":-12.001031,"median":-8.442474,"eighty":-4.662395,"marketCap":1179702028},{"date":"2023-12-29","current":-5.277319,"twenty":-12.001031,"median":-8.374928,"eighty":-4.65615,"marketCap":1247289124},{"date":"2024-01-05","current":-5.597945,"twenty":-12.001031,"median":-8.31341,"eighty":-4.649904,"marketCap":1323068594},{"date":"2024-01-12","current":-5.60661,"twenty":-12.001031,"median":-8.201319,"eighty":-4.649904,"marketCap":1325116688},{"date":"2024-01-19","current":-4.991356,"twenty":-12.001031,"median":-8.150833,"eighty":-4.643659,"marketCap":1179702028},{"date":"2024-01-26","current":-4.722724,"twenty":-12.001031,"median":-8.091771,"eighty":-4.649904,"marketCap":1116211121},{"date":"2024-02-02","current":-4.57541,"twenty":-12.001031,"median":-7.991699,"eighty":-4.636607,"marketCap":1081393526},{"date":"2024-02-09","current":-4.610072,"twenty":-12.001031,"median":-7.838887,"eighty":-4.610072,"marketCap":1089585901},{"date":"2024-02-16","current":-4.88737,"twenty":-12.001031,"median":-7.609687,"eighty":-4.610072,"marketCap":1155124903},{"date":"2024-02-23","current":-5.043349,"twenty":-12.001031,"median":-7.563845,"eighty":-4.610072,"marketCap":1191990591},{"date":"2024-03-01","current":-5.123286,"twenty":-12.001031,"median":-7.435334,"eighty":-4.610072,"marketCap":1160624100},{"date":"2024-03-08","current":-4.713787,"twenty":-12.001031,"median":-7.353397,"eighty":-4.610072,"marketCap":1067856632},{"date":"2024-03-15","current":-4.449888,"twenty":-12.001031,"median":-7.26889,"eighty":-4.603663,"marketCap":1008073152},{"date":"2024-03-22","current":-4.995886,"twenty":-12.001031,"median":-7.213664,"eighty":-4.593526,"marketCap":1131763110},{"date":"2024-03-28","current":-4.686487,"twenty":-12.001031,"median":-7.152558,"eighty":-4.584506,"marketCap":1061672134},{"date":"2024-04-05","current":-4.185989,"twenty":-12.001031,"median":-7.089132,"eighty":-4.565435,"marketCap":948289673},{"date":"2024-04-12","current":-4.640987,"twenty":-12.001031,"median":-7.047905,"eighty":-4.535634,"marketCap":1051364637},{"date":"2024-04-19","current":-4.094989,"twenty":-12.001031,"median":-6.983186,"eighty":-4.459327,"marketCap":927674680},{"date":"2024-04-26","current":-3.788907,"twenty":-12.001031,"median":-6.960486,"eighty":-4.426785,"marketCap":858335308},{"date":"2024-05-03","current":-4.080362,"twenty":-12.001031,"median":-6.912774,"eighty":-4.341139,"marketCap":924361101},{"date":"2024-05-10","current":-5.283475,"twenty":-12.001031,"median":-6.87327,"eighty":-4.341139,"marketCap":1102053649},{"date":"2024-05-17","current":-6.401514,"twenty":-12.001031,"median":-6.822696,"eighty":-4.341139,"marketCap":1335259759},{"date":"2024-05-24","current":-6.262996,"twenty":-12.001031,"median":-6.79385,"eighty":-4.398243,"marketCap":1306366967},{"date":"2024-05-31","current":-6.500455,"twenty":-12.001031,"median":-6.79385,"eighty":-4.442608,"marketCap":1355897468},{"date":"2024-06-07","current":-6.371831,"twenty":-12.001031,"median":-6.79385,"eighty":-4.464497,"marketCap":1329068446},{"date":"2024-06-14","current":-6.164054,"twenty":-12.001031,"median":-6.79982,"eighty":-4.547101,"marketCap":1285729258},{"date":"2024-06-21","current":-6.084901,"twenty":-12.001031,"median":-6.807212,"eighty":-4.575047,"marketCap":1269219091},{"date":"2024-06-28","current":-6.045324,"twenty":-12.003012,"median":-6.830789,"eighty":-4.593526,"marketCap":1260964007},{"date":"2024-07-05","current":-6.342149,"twenty":-12.003012,"median":-6.830789,"eighty":-4.610072,"marketCap":1322877134},{"date":"2024-07-12","current":-6.96548,"twenty":-12.003012,"median":-6.839984,"eighty":-4.630756,"marketCap":1452894699},{"date":"2024-07-15","current":-7.074316,"twenty":-12.003012,"median":-6.860942,"eighty":-4.636875,"marketCap":1475596179},{"date":"2024-08-02","current":-7.034739,"twenty":-12.01194,"median":-6.912774,"eighty":-4.705393,"marketCap":1467341095},{"date":"2024-08-09","current":-11.29889,"twenty":-12.01194,"median":-6.946957,"eighty":-4.741087,"marketCap":1648880909},{"date":"2024-08-16","current":-10.81688,"twenty":-12.01194,"median":-6.980841,"eighty":-4.774717,"marketCap":1578539691},{"date":"2024-08-23","current":-11.242183,"twenty":-12.01194,"median":-7.018642,"eighty":-4.826711,"marketCap":1640605472},{"date":"2024-08-30","current":-12.234557,"twenty":-12.014338,"median":-7.070457,"eighty":-4.877587,"marketCap":1785425627},{"date":"2024-09-06","current":-11.525718,"twenty":-12.035026,"median":-7.101921,"eighty":-4.88737,"marketCap":1681982659},{"date":"2024-09-13","current":-10.987001,"twenty":-12.035026,"median":-7.152558,"eighty":-4.913366,"marketCap":1603366004},{"date":"2024-09-20","current":-11.554072,"twenty":-12.035026,"median":-7.224485,"eighty":-4.977686,"marketCap":1686120378},{"date":"2024-09-27","current":-10.745996,"twenty":-12.035026,"median":-7.281714,"eighty":-4.996539,"marketCap":1568195394},{"date":"2024-10-04","current":-10.519167,"twenty":-12.035026,"median":-7.356877,"eighty":-5.042892,"marketCap":1535093645},{"date":"2024-10-11","current":-10.093864,"twenty":-12.035026,"median":-7.468832,"eighty":-5.095343,"marketCap":1473027864},{"date":"2024-10-18","current":-10.618405,"twenty":-12.035026,"median":-7.580205,"eighty":-5.147336,"marketCap":1549575660},{"date":"2024-10-25","current":-11.596602,"twenty":-12.035026,"median":-7.766312,"eighty":-5.164667,"marketCap":1692326956},{"date":"2024-10-31","current":-11.865961,"twenty":-12.035026,"median":-8.017533,"eighty":-5.202028,"marketCap":1731635284},{"date":"2024-11-08","current":-12.831088,"twenty":-12.05083,"median":-8.266748,"eighty":-5.240678,"marketCap":1588706819},{"date":"2024-11-15","current":-12.463052,"twenty":-12.117301,"median":-8.515042,"eighty":-5.262947,"marketCap":1543137653},{"date":"2024-11-22","current":-12.529967,"twenty":-12.127993,"median":-8.696528,"eighty":-5.277751,"marketCap":1551422956},{"date":"2024-11-29","current":-12.546696,"twenty":-12.162273,"median":-8.89774,"eighty":-5.307206,"marketCap":1553494282},{"date":"2024-12-06","current":-13.11548,"twenty":-12.179299,"median":-9.041252,"eighty":-5.338414,"marketCap":1623919356},{"date":"2024-12-13","current":-12.713985,"twenty":-12.207624,"median":-9.17232,"eighty":-5.363975,"marketCap":1574207539},{"date":"2024-12-20","current":-12.362678,"twenty":-12.232231,"median":-9.243731,"eighty":-5.409294,"marketCap":1530709699},{"date":"2024-12-27","current":-12.914733,"twenty":-12.259544,"median":-9.356661,"eighty":-5.41898,"marketCap":1599063448},{"date":"2025-01-03","current":-13.098751,"twenty":-12.26852,"median":-9.418291,"eighty":-5.454663,"marketCap":1621848030},{"date":"2025-01-10","current":-13.466787,"twenty":-12.292012,"median":-9.454684,"eighty":-5.48209,"marketCap":1667417196},{"date":"2025-01-17","current":-11.810623,"twenty":-12.304269,"median":-9.573636,"eighty":-5.520157,"marketCap":1462355951},{"date":"2025-01-24","current":-12.931462,"twenty":-12.325269,"median":-9.656044,"eighty":-5.52783,"marketCap":1601134773},{"date":"2025-01-31","current":-13.165667,"twenty":-12.367034,"median":-9.698399,"eighty":-5.550842,"marketCap":1630133333},{"date":"2025-02-07","current":-14.604354,"twenty":-12.442894,"median":-9.725843,"eighty":-5.566615,"marketCap":1808267344},{"date":"2025-02-14","current":-14.754915,"twenty":-12.465502,"median":-9.795847,"eighty":-5.593158,"marketCap":1826909276},{"date":"2025-02-21","current":-15.708464,"twenty":-12.479871,"median":-9.828959,"eighty":-5.626683,"marketCap":1944974841},{"date":"2025-02-28","current":-19.913045,"twenty":-12.502,"median":-9.865139,"eighty":-5.652335,"marketCap":1769891369},{"date":"2025-03-07","current":-18.47893,"twenty":-12.529967,"median":-9.901904,"eighty":-5.678879,"marketCap":1642425757},{"date":"2025-03-14","current":-17.726607,"twenty":-12.546696,"median":-9.940471,"eighty":-5.714205,"marketCap":1575558550},{"date":"2025-03-21","current":-18.079258,"twenty":-12.59352,"median":-9.969395,"eighty":-5.738213,"marketCap":1606902553},{"date":"2025-03-28","current":-18.4084,"twenty":-12.615114,"median":-10.036268,"eighty":-5.765731,"marketCap":1636156956},{"date":"2025-04-04","current":-17.232895,"twenty":-12.640439,"median":-10.100661,"eighty":-5.812016,"marketCap":1531676946}],"updateTime":1743865241394}}}